About the Authors
- Carlos Escobar
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
* E-mail: escobar_cervantes_carlos@hotmail.com
Affiliation Cardiology Department, Hospital Universitario La Paz, Madrid, Spain
- Xavier Borrás
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Ramón Bover Freire
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital Clínico San Carlos, CIBERCV, Madrid, Spain
- Carlos González-Juanatey
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital Universitario Lucus Augusti, Lugo, Spain
- Miren Morillas
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital de Galdakao, Galdakao, Bizkaia, Spain
- Alfonso Valle Muñoz
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital Marina Salud, Denia, Alicante, Spain
- Juan José Gómez-Doblas
-
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cardiology Department, Hospital Universitario Virgen de la Victoria, CIBERCV, Málaga, Spain
Competing Interests
CE has served on advisory boards for Boehringer, Pfizer/Bristol-Myers Squibb (BMS), Bayer and Daiichi Sankyo, and also received speaker fees from these companies. RBF has served on advisory boards for Boehringer, Novartis and Astra-Zeneca. CG-J has served on advisory boards for Boehringer, Astra-Zeneca, Novartis, and Bayer, and has also received research funding from Abbott, Boehringer, Astra-Zeneca, and Pfizer. AVM has served on advisory boards for MSD, Boehringher, Bayer, Daiichi, and Novartis; and has received honoraria for providing expert testimony from MSD, Boehringher, Bayer, Daiichi, Novartis, Amgen, Sanofi, Pzifer, Janssen, Astrazeneca, Servier, and Rovi. JJGD has received honoraria for advisory services from Bayer, Astrazeneca, MSD, Daiichi, BMS, Amgen and Sanofi. The other authors declare that they have no other competing interests. There are no patents, products in development or marketed products to declare. This does not alter our adherence to Plos One policies on sharing data and materials.